Increased Melatonin Signaling Is a Risk Factor for Type 2 Diabetes

Cell Metabolism

Volumn 23, Issue 6, 2016, Pages 1067-1077

  Tuomi, Tiinamaija ^a,b,c   Nagorny, Cecilia L F ^d   Singh, Pratibha ^d   Bennet, Hedvig ^d   Yu, Qian ^e   Alenkvist, Ida ^e   Isomaa, Bo ^b,c,f   Östman, Bjarne ^b   Söderström, Johan ^b,c   Pesonen, Anu Katriina ^c   Martikainen, Silja ^c   Räikkönen, Katri ^c   Forsén, Tom ^b   Hakaste, Liisa ^a,b,c   Almgren, Peter ^c,d   Storm, Petter ^d   Asplund, Olof ^d   Shcherbina, Liliya ^d   Fex, Malin ^d   Fadista, João ^d   Tengholm, Anders ^e   Wierup, Nils ^d   Groop, Leif ^c,d   Mulder, Hindrik ^d   more..

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b FOLKHÄLSAN RESEARCH CENTER   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d LUND UNIVERSITY DIABETES CENTRE   (Sweden)

^e UPPSALA UNIVERSITY   (Sweden)

^f Department of Social Services and Health Care ^*  (Finland)

Author keywords

gene targeting; insulin; islets; recall by genotype; RNA sequencing

Indexed keywords

CYCLIC AMP; GLUCOSE; MELATONIN 1 RECEPTOR; MELATONIN RECEPTOR 1B; UNCLASSIFIED DRUG; INSULIN; MELATONIN; MELATONIN RECEPTOR;

ADULT; ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; HUMAN; HYPERGLYCEMIA; INSULIN RELEASE; KNOCKOUT MOUSE; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS; RISK FACTOR; ANIMAL; DRUG EFFECTS; GENETIC PREDISPOSITION; GENETICS; HETEROZYGOTE; METABOLISM; SECRETION (PROCESS); SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

ANIMALS; CYCLIC AMP; DIABETES MELLITUS, TYPE 2; GENETIC PREDISPOSITION TO DISEASE; GLUCOSE; HETEROZYGOTE; HUMANS; INSULIN; INSULIN-SECRETING CELLS; MELATONIN; MICE, KNOCKOUT; POLYMORPHISM, SINGLE NUCLEOTIDE; QUANTITATIVE TRAIT LOCI; RECEPTORS, MELATONIN; RISK FACTORS; SIGNAL TRANSDUCTION;

EID: 84966693052     PISSN: 15504131     EISSN: 19327420     Source Type: Journal    
DOI: 10.1016/j.cmet.2016.04.009     Document Type: Article

References (44)

1. S.L. Anderson, J.M. Trujillo, M. McDermott, and J.J. Saseen Determining predictors of response to exenatide in type 2 diabetes J. Am. Pharm. Assoc. 52 2012 466 471
2. L.E. Andersson, B. Valtat, A. Bagge, V.V. Sharoyko, D.G. Nicholls, P. Ravassard, R. Scharfmann, P. Spégel, and H. Mulder Characterization of stimulus-secretion coupling in the human pancreatic EndoC-βH1 beta cell line PLoS ONE 10 2015 e0120879
3. I. Bazwinsky-Wutschke, L. Bieseke, E. Mühlbauer, and E. Peschke Influence of melatonin receptor signalling on parameters involved in blood glucose regulation J. Pineal Res. 56 2014 82 96
4. R.N. Bergman, M. Ader, K. Huecking, and G. Van Citters Accurate assessment of beta-cell function: the hyperbolic correction Diabetes 51 Suppl 1 2002 S212 S220
5. D.M. Blodgett, A. Nowosielska, S. Afik, S. Pechhold, A.J. Cura, N.J. Kennedy, S. Kim, A. Kucukural, R.J. Davis, S.C. Kent, and et al. Novel observations from next-generation RNA sequencing of highly purified human adult and fetal islet cell subsets Diabetes 64 2015 3172 3181
6. N. Bouatia-Naji, A. Bonnefond, C. Cavalcanti-Proença, T. Sparsø, J. Holmkvist, M. Marchand, J. Delplanque, S. Lobbens, G. Rocheleau, E. Durand, and et al. A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk Nat. Genet. 41 2009 89 94
7. O. Dyachok, Y. Isakov, J. Sågetorp, and A. Tengholm Oscillations of cyclic AMP in hormone-stimulated insulin-secreting beta-cells Nature 439 2006 349 352
8. J. Fadista, P. Vikman, E.O. Laakso, I.G. Mollet, J.L. Esguerra, J. Taneera, P. Storm, P. Osmark, C. Ladenvall, R.B. Prasad, and et al. Global genomic and transcriptomic analysis of human pancreatic islets reveals novel genes influencing glucose metabolism Proc. Natl. Acad. Sci. USA 111 2014 13924 13929
9. M. Fex, M. Dekker Nitert, N. Wierup, C. Ling, F. Sundler, and H. Mulder Enhanced mitochondrial metabolism may account for the adaptation to insulin resistance in islets from high fat diet-fed C57BL/6J mice Diabetologia 50 2007 74 83
10. M. Garaulet, P. Gómez-Abellán, P. Rubio-Sastre, J.A. Madrid, R. Saxena, and F.A. Scheer Common type 2 diabetes risk variant in MTNR1B worsens the deleterious effect of melatonin on glucose tolerance in humans Metabolism 64 2015 1650 1657
11. K.J. Gaulton, T. Ferreira, Y. Lee, A. Raimondo, R. Mägi, M.E. Reschen, A. Mahajan, A. Locke, N.W. Rayner, N. Robertson, et al. DIAbetes Genetics Replication And Meta-analysis (DIAGRAM) Consortium Genetic fine mapping and genomic annotation defines causal mechanisms at type 2 diabetes susceptibility loci Nat. Genet. 47 2015 1415 1425
12. R.L. Hanson, R.E. Pratley, C. Bogardus, K.M. Narayan, J.M. Roumain, G. Imperatore, A. Fagot-Campagna, D.J. Pettitt, P.H. Bennett, and W.C. Knowler Evaluation of simple indices of insulin sensitivity and insulin secretion for use in epidemiologic studies Am. J. Epidemiol. 151 2000 190 198
13. + channel-dependent and -independent glucose-stimulated insulin secretion Diabetes 49 2000 424 430
14. B. Isomaa, B. Forsén, K. Lahti, N. Holmström, J. Wadén, O. Matintupa, P. Almgren, J.G. Eriksson, V. Lyssenko, M.R. Taskinen, and et al. A family history of diabetes is associated with reduced physical fitness in the Prevalence, Prediction and Prevention of Diabetes (PPP)-Botnia study Diabetologia 53 2010 1709 1713
15. X. Jin, C. von Gall, R.L. Pieschl, V.K. Gribkoff, J.H. Stehle, S.M. Reppert, and D.R. Weaver Targeted disruption of the mouse Mel(1b) melatonin receptor Mol. Cell. Biol. 23 2003 1054 1060
16. A. Jonsson, C. Ladenvall, T.S. Ahluwalia, J. Kravic, U. Krus, J. Taneera, B. Isomaa, T. Tuomi, E. Renström, L. Groop, and V. Lyssenko Effects of common genetic variants associated with type 2 diabetes and glycemic traits on α- and β-cell function and insulin action in humans Diabetes 62 2013 2978 2983
17. D.M. Kemp, M. Ubeda, and J.F. Habener Identification and functional characterization of melatonin Mel 1a receptors in pancreatic beta cells: potential role in incretin-mediated cell function by sensitization of cAMP signaling Mol. Cell. Endocrinol. 191 2002 157 166
18. J.K. Kim, Y.J. Kim, J.J. Fillmore, Y. Chen, I. Moore, J. Lee, M. Yuan, Z.W. Li, M. Karin, P. Perret, and et al. Prevention of fat-induced insulin resistance by salicylate J. Clin. Invest. 108 2001 437 446
19. V. Lyssenko, A. Jonsson, P. Almgren, N. Pulizzi, B. Isomaa, T. Tuomi, G. Berglund, D. Altshuler, P. Nilsson, and L. Groop Clinical risk factors, DNA variants, and the development of type 2 diabetes N. Engl. J. Med. 359 2008 2220 2232
20. V. Lyssenko, C.L. Nagorny, M.R. Erdos, N. Wierup, A. Jonsson, P. Spégel, M. Bugliani, R. Saxena, M. Fex, N. Pulizzi, and et al. Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion Nat. Genet. 41 2009 82 88
21. B. Marcheva, K.M. Ramsey, A. Affinati, and J. Bass Clock genes and metabolic disease J. Appl. Physiol. 107 2009 1638 1646
22. B. Marcheva, K.M. Ramsey, E.D. Buhr, Y. Kobayashi, H. Su, C.H. Ko, G. Ivanova, C. Omura, S. Mo, M.H. Vitaterna, and et al. Disruption of the clock components CLOCK and BMAL1 leads to hypoinsulinaemia and diabetes Nature 466 2010 627 631
23. M. Matsuda, and R.A. DeFronzo Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp Diabetes Care 22 1999 1462 1470
24. E. Mühlbauer, E. Albrecht, K. Hofmann, I. Bazwinsky-Wutschke, and E. Peschke Melatonin inhibits insulin secretion in rat insulinoma β-cells (INS-1) heterologously expressing the human melatonin receptor isoform MT2 J. Pineal Res. 51 2011 361 372
25. E. Mühlbauer, E. Albrecht, I. Bazwinsky-Wutschke, and E. Peschke Melatonin influences insulin secretion primarily via MT(1) receptors in rat insulinoma cells (INS-1) and mouse pancreatic islets J. Pineal Res. 52 2012 446 459
26. H. Mulder, C.L.F. Nagorny, V. Lyssenko, and L. Groop Melatonin receptors in pancreatic islets: good morning to a novel type 2 diabetes gene Diabetologia 52 2009 1240 1249
27. C.L.F. Nagorny, R. Sathanoori, U. Voss, H. Mulder, and N. Wierup Distribution of melatonin receptors in murine pancreatic islets J. Pineal Res. 50 2011 412 417
28. E. Peschke, A.G. Bach, and E. Mühlbauer Parallel signaling pathways of melatonin in the pancreatic beta-cell J. Pineal Res. 40 2006 184 191
29. E. Peschke, I. Bähr, and E. Mühlbauer Experimental and clinical aspects of melatonin and clock genes in diabetes J. Pineal Res. 59 2015 1 23
30. R.B. Prasad, and L. Groop Genetics of type 2 diabetes-pitfalls and possibilities Genes (Basel) 6 2015 87 123
31. I. Prokopenko, C. Langenberg, J.C. Florez, R. Saxena, N. Soranzo, G. Thorleifsson, R.J. Loos, A.K. Manning, A.U. Jackson, Y. Aulchenko, and et al. Variants in MTNR1B influence fasting glucose levels Nat. Genet. 41 2009 77 81
32. R.D. Ramracheya, D.S. Muller, P.E. Squires, H. Brereton, D. Sugden, G.C. Huang, S.A. Amiel, P.M. Jones, and S.J. Persaud Function and expression of melatonin receptors on human pancreatic islets J. Pineal Res. 44 2008 273 279
33. P. Ravassard, Y. Hazhouz, S. Pechberty, E. Bricout-Neveu, M. Armanet, P. Czernichow, and R. Scharfmann A genetically engineered human pancreatic β cell line exhibiting glucose-inducible insulin secretion J. Clin. Invest. 121 2011 3589 3597
34. F. Renström, R.W. Koivula, T.V. Varga, G. Hallmans, H. Mulder, J.C. Florez, F.B. Hu, and P.W. Franks Season-dependent associations of circadian rhythm-regulating loci (CRY1, CRY2 and MTNR1B) and glucose homeostasis: the GLACIER Study Diabetologia 58 2015 997 1005
35. T. Rönn, J. Wen, Z. Yang, B. Lu, Y. Du, L. Groop, R. Hu, and C. Ling A common variant in MTNR1B, encoding melatonin receptor 1B, is associated with type 2 diabetes and fasting plasma glucose in Han Chinese individuals Diabetologia 52 2009 830 833
36. P. Rubio-Sastre, F.A. Scheer, P. Gómez-Abellán, J.A. Madrid, and M. Garaulet Acute melatonin administration in humans impairs glucose tolerance in both the morning and evening Sleep 37 2014 1715 1719
37. F.A. Scheer, M.F. Hilton, C.S. Mantzoros, and S.A. Shea Adverse metabolic and cardiovascular consequences of circadian misalignment Proc. Natl. Acad. Sci. USA 106 2009 4453 4458
38. J.E. Shaw, R.A. Sicree, and P.Z. Zimmet Global estimates of the prevalence of diabetes for 2010 and 2030 Diabetes Res. Clin. Pract. 87 2010 4 14
39. Y. Tang, A.S. Axelsson, P. Spégel, L.E. Andersson, H. Mulder, L.C. Groop, E. Renström, and A.H. Rosengren Genotype-based treatment of type 2 diabetes with an α2A-adrenergic receptor antagonist Sci. Transl. Med. 6 2014 257ra139
40. B.G. Teodoro, F.G. Baraldi, I.H. Sampaio, L.H. Bomfim, A.L. Queiroz, M.A. Passos, E.M. Carneiro, L.C. Alberici, R. Gomis, F.G. Amaral, and et al. Melatonin prevents mitochondrial dysfunction and insulin resistance in rat skeletal muscle J. Pineal Res. 57 2014 155 167
41. G. Tian, S. Sandler, E. Gylfe, and A. Tengholm Glucose- and hormone-induced cAMP oscillations in α- and β-cells within intact pancreatic islets Diabetes 60 2011 1535 1543
42. J.M. Torres, N.J. Cox, and L.H. Philipson Genome wide association studies for diabetes: perspective on results and challenges Pediatr. Diabetes 14 2013 90 96
43. P.M. Visscher, M.A. Brown, M.I. McCarthy, and J. Yang Five years of GWAS discovery Am. J. Hum. Genet. 90 2012 7 24
44. C. von Gall, J.H. Stehle, and D.R. Weaver Mammalian melatonin receptors: molecular biology and signal transduction Cell Tissue Res. 309 2002 151 162